KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other financing activities: 2009-2019

Historic Other financing activities for Neogenomics (NEO) over the last 2 years, with Dec 2019 value amounting to $8,000.

  • Neogenomics' Other financing activities was N/A to $8,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $569,000, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2019, which is 83.85% up from last year.
  • Neogenomics' Other financing activities amounted to $8,000 in Q4 2019, which was down 91.75% from $97,000 recorded in Q3 2019.
  • In the past 5 years, Neogenomics' Other financing activities ranged from a high of $576,000 in Q2 2018 and a low of -$112,000 during Q3 2017.
  • Its 3-year average for Other financing activities is $136,200, with a median of $97,000 in 2019.
  • Data for Neogenomics' Other financing activities shows a peak YoY rose of 15.46% (in 2017) over the last 5 years.
  • Over the past 4 years, Neogenomics' Other financing activities (Quarterly) stood at $97,000 in 2016, then rose by 15.46% to -$112,000 in 2017, then reached $576,000 in 2018, then reached $8,000 in 2019.
  • Its Other financing activities was $8,000 in Q4 2019, compared to $97,000 in Q3 2019 and $576,000 in Q2 2018.